{
    "medicine_id": "130711a4b3386d87cd91f4377f79fc3896ee9a3f",
    "platform_id": "DB01259",
    "metadata": {
        "name": "Lapatinib 250 mg 1 Tablet",
        "composition": "250 mg 1 Lapatinib",
        "clinical_particulars": {
            "therapeutic_indications": "Indicated in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress the human epidermal receptor type 2 HER2 protein and who have received prior therapy including an anthracycline a taxane and trastuzuma",
            "contraindications": {
                "disease": "There has been a report of one patient who took 3 000 mg of lapatinib for 10 days This patient had grade 3 diarrhea and vomiting on day 10",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Lapatinib is a small molecule and a member of the 4 anilinoquinazoline class of kinase inhibitors An anti cancer drug lapatinib was developed by GlaxoSmithKline GSK as a treatment for solid tumours such as breast and lung cancer It was approved by the FDA on March 13 2007 for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug capecitabine",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Afatinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The serum concentration of Bosutinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Edoxaban can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Ledipasvir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The metabolism of Lomitapide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The serum concentration of Naloxegol can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The serum concentration of Pazopanib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The serum concentration of Prucalopride can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Ranolazine can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Silodosin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The serum concentration of Topotecan can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The serum concentration of Lapatinib can be decreased when it is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Eliglustat can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The serum concentration of Everolimus can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The serum concentration of Rifaximin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08933",
                        "description": "The serum concentration of Lapatinib can be increased when it is combined with Luliconazole"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Colchicine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The metabolism of Fentanyl can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The metabolism of Iloperidone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Boceprevir"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB13179",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Troleandomycin"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Naloxone"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB02520",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Ditiocarb"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB09101",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Elvitegravir"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11779",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Danoprevir"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The metabolism of Ergotamine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The metabolism of Conivaptan can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Tipranavir can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The metabolism of Saquinavir can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "The metabolism of Darunavir can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The metabolism of Lopinavir can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB01256",
                        "description": "The metabolism of Retapamulin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The metabolism of Tofacitinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The metabolism of Vardenafil can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The metabolism of Eszopiclone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The metabolism of Zopiclone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Lovastatin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Lapatinib can be increased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The metabolism of Lapatinib can be increased when combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Lapatinib can be increased when combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00648",
                        "description": "The metabolism of Lapatinib can be increased when combined with Mitotane"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Lapatinib can be increased when combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Lapatinib can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Lapatinib can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The metabolism of Lapatinib can be increased when combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Lapatinib can be increased when combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The metabolism of Lapatinib can be increased when combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The metabolism of Lapatinib can be increased when combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Lapatinib can be increased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The metabolism of Lapatinib can be increased when combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The serum concentration of Acetaminophen can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The serum concentration of Propacetamol can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The metabolism of Alfuzosin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The metabolism of Alprazolam can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Lapatinib can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The serum concentration of Warfarin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The serum concentration of Acenocoumarol can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The serum concentration of R warfarin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08735",
                        "description": "The serum concentration of R S Warfarin alcohol can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08736",
                        "description": "The serum concentration of S R Warfarin alcohol can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The serum concentration of S Warfarin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The serum concentration of Midazolam can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Tacrolimus can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The metabolism of Atorvastatin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The excretion of Vincristine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The serum concentration of Doxorubicin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The serum concentration of Lapatinib can be decreased when it is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Indenolol"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Propranolol is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The metabolism of Lapatinib can be increased when combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00455",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Loratadine"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Nabilone"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01132",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Pioglitazone"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Topiroxostat"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Trimethoprim"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Clopidogrel"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Trametinib"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Salmeterol"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Felodipine"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Betrixaban can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Lapatinib may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Lapatinib can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The serum concentration of Pravastatin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Morphine can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "The serum concentration of Tenofovir disoproxil can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The serum concentration of Clobazam can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The serum concentration of Bisoprolol can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The serum concentration of Mannitol can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Clomifene can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Fexofenadine can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The serum concentration of Tegaserod can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Sitagliptin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Simeprevir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Ambrisentan can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The serum concentration of Apixaban can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Odanacatib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Linagliptin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "The serum concentration of Sofosbuvir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Umeclidinium can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The serum concentration of Nintedanib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Technetium Tc 99m sestamibi can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The serum concentration of Dasabuvir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The serum concentration of Ombitasvir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The serum concentration of Paritaprevir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Selexipag can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The serum concentration of Elbasvir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Grazoprevir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Velpatasvir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The serum concentration of Tezacaftor can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The serum concentration of Talinolol can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The serum concentration of Ertugliflozin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The serum concentration of Revefenacin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Valspodar can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The serum concentration of Duvelisib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Elagolix can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The serum concentration of Avatrombopag can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Voxilaprevir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The serum concentration of Gilteritinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The serum concentration of Rucaparib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Grapiprant can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "The serum concentration of Lusutrombopag can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The serum concentration of Pibrentasvir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The serum concentration of Glecaprevir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The serum concentration of Tenofovir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The serum concentration of Fedratinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Lasmiditan can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Enfortumab vedotin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Darolutamide can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Lemborexant can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The serum concentration of Tazemetostat can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Lapatinib can be increased when it is combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Methylene blue can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The serum concentration of Rivaroxaban can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Ticagrelor can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The serum concentration of Selumetinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "The serum concentration of Ripretinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The serum concentration of Belinostat can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Belantamab mafodotin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The metabolism of Aripiprazole can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The metabolism of Aripiprazole lauroxil can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Dabigatran etexilate can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Arformoterol"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pheniramine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Fleroxacin"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Farnesyl thiopyrophosphate"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Tandutinib"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cariporide"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Farnesyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Geranylgeranyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Coumaphos"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dichlorvos"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Fenthion"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cicletanine"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Brompheniramine"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Celiprolol"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The serum concentration of Romidepsin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The serum concentration of Cyclosporine can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The serum concentration of Sirolimus can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The serum concentration of Quinidine can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Temsirolimus can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The serum concentration of Etoposide can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The serum concentration of Dactinomycin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The serum concentration of Cobimetinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The serum concentration of Trastuzumab emtansine can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The serum concentration of Cabazitaxel can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The serum concentration of Crizotinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The serum concentration of Ceritinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Osimertinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Talazoparib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The serum concentration of Dacomitinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The serum concentration of Copanlisib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The serum concentration of Lapatinib can be increased when it is combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The serum concentration of Lapatinib can be increased when it is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The serum concentration of Lapatinib can be increased when it is combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The serum concentration of Tolvaptan can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The serum concentration of Lapatinib can be increased when it is combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The serum concentration of Bendamustine can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Carfilzomib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The serum concentration of Binimetinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The serum concentration of Gemcitabine can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Lapatinib can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Lorazepam"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Phentermine"
                    },
                    {
                        "drugbank-id": "DB00426",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Famciclovir"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Cephalexin"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Rosuvastatin"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Pranlukast can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "The metabolism of Allylestrenol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "The metabolism of Roflumilast can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The metabolism of Vorapaxar can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The metabolism of Suvorexant can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Tasimelteon can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The metabolism of Vitamin D can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "The metabolism of Dihydroergocornine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12515",
                        "description": "The metabolism of 9 aminocamptothecin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12952",
                        "description": "The metabolism of Methylprednisone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The metabolism of Dihydroergocryptine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The metabolism of Drospirenone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The metabolism of Rufinamide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The metabolism of Elexacaftor can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06717",
                        "description": "The metabolism of Fosaprepitant can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The metabolism of Tenofovir alafenamide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The metabolism of Methysergide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The metabolism of Vandetanib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Acalabrutinib"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Vinblastine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Panobinostat can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The metabolism of Venetoclax can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The metabolism of Vinflunine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The metabolism of Baricitinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The metabolism of Ivosidenib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Cyclophosphamide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Ifosfamide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Brigatinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Enasidenib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The metabolism of Dofetilide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The metabolism of Busulfan can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The metabolism of Tianeptine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Alpelisib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Sunitinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Clonidine"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The metabolism of Siponimod can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The metabolism of Methotrexate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Vinorelbine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The metabolism of Thiotepa can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "The metabolism of Alectinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB15035",
                        "description": "The metabolism of Zanubrutinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The metabolism of Idelalisib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The metabolism of Cabergoline can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The metabolism of Vindesine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The metabolism of Ixabepilone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The metabolism of Ruxolitinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The metabolism of Palbociclib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09143",
                        "description": "The metabolism of Sonidegib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The metabolism of Neratinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The metabolism of Erdafitinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "The metabolism of Ixazomib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The metabolism of Abemaciclib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Nelfinavir can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Isavuconazole can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Medical Cannabis can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The metabolism of Nabiximols can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB00673",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Aprepitant"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Indinavir"
                    },
                    {
                        "drugbank-id": "DB11737",
                        "description": "The metabolism of Lapatinib can be increased when combined with Icotinib"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The metabolism of Lapatinib can be increased when combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The metabolism of Lapatinib can be increased when combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The metabolism of Lapatinib can be increased when combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The metabolism of Lapatinib can be increased when combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The metabolism of Lapatinib can be increased when combined with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The metabolism of Lapatinib can be increased when combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The metabolism of Lapatinib can be increased when combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The metabolism of Lapatinib can be increased when combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The metabolism of Lapatinib can be increased when combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The metabolism of Lapatinib can be increased when combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The metabolism of Lapatinib can be increased when combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The metabolism of Lapatinib can be increased when combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The metabolism of Lapatinib can be increased when combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The metabolism of Lapatinib can be increased when combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The metabolism of Lapatinib can be increased when combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The metabolism of Lapatinib can be increased when combined with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The metabolism of Lapatinib can be increased when combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The metabolism of Lapatinib can be increased when combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The metabolism of Lapatinib can be increased when combined with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The metabolism of Lapatinib can be increased when combined with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The metabolism of Lapatinib can be increased when combined with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The metabolism of Lapatinib can be increased when combined with Cortisone"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The metabolism of Lapatinib can be increased when combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The metabolism of Lapatinib can be increased when combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The metabolism of Lapatinib can be increased when combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The metabolism of Lapatinib can be increased when combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The metabolism of Lapatinib can be increased when combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The metabolism of Lapatinib can be increased when combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The metabolism of Lapatinib can be increased when combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The metabolism of Lapatinib can be increased when combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Norethisterone"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Dutasteride"
                    },
                    {
                        "drugbank-id": "DB04856",
                        "description": "The metabolism of Dexloxiglumide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Levonorgestrel"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Flutamide"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Dextromethorphan"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Zaleplon"
                    },
                    {
                        "drugbank-id": "DB01103",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Quinacrine"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Finasteride"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The metabolism of Udenafil can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The metabolism of Saxagliptin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06419",
                        "description": "The metabolism of Cethromycin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06652",
                        "description": "The metabolism of Vicriviroc can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The metabolism of Ivacaftor can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "The metabolism of Perampanel can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The metabolism of Daclatasvir can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12301",
                        "description": "The metabolism of Doravirine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The metabolism of Hydrocortisone cypionate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Buspirone"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Tadalafil"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Clindamycin"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Asunaprevir can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Triazolam"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Estrone"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00205",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Pyrimethamine"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Ketoprofen"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Rofecoxib"
                    },
                    {
                        "drugbank-id": "DB08875",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Cabozantinib"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Montelukast"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Piroxicam"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Amodiaquine"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Nilutamide"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Metronidazole"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Nicotine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The metabolism of Torasemide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The metabolism of Dapsone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The metabolism of Trimethadione can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "The metabolism of Sulfadiazine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The metabolism of Mephenytoin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The metabolism of Diclofenac can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The metabolism of Paramethadione can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The metabolism of Tretinoin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The metabolism of Naproxen can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00799",
                        "description": "The metabolism of Tazarotene can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Propofol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Terbinafine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "The metabolism of Repaglinide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The metabolism of Almotriptan can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The metabolism of Buprenorphine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "The metabolism of Azelastine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The metabolism of Selegiline can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The metabolism of Tolbutamide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The metabolism of Ketamine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "The metabolism of Mestranol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Aminophenazone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Antipyrine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The metabolism of Licofelone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The metabolism of Beraprost can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06510",
                        "description": "The metabolism of Muraglitazar can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The metabolism of Ketobemidone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Seratrodast can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The metabolism of Benzyl alcohol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The metabolism of Perospirone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "The metabolism of Riociguat can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The metabolism of Vortioxetine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The metabolism of Olodaterol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The metabolism of Lobeglitazone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09199",
                        "description": "The metabolism of Netoglitazone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09200",
                        "description": "The metabolism of Rivoglitazone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09201",
                        "description": "The metabolism of Ciglitazone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12130",
                        "description": "The metabolism of Lorlatinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12781",
                        "description": "The metabolism of Balaglitazone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "The metabolism of Testosterone cypionate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Testosterone enanthate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "The metabolism of Testosterone undecanoate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Bezafibrate"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB01698",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Rutin"
                    },
                    {
                        "drugbank-id": "DB04216",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Quercetin"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB11632",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Opicapone"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Candesartan"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The metabolism of Dexibuprofen can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08502",
                        "description": "The metabolism of Capravirine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The metabolism of Ketorolac can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Diethylstilbestrol"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Raloxifene"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Losartan"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Amitriptyline can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Omeprazole can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The metabolism of Celecoxib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The metabolism of Zidovudine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Chloroquine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The metabolism of Mycophenolate mofetil can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The metabolism of Estradiol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The metabolism of Ibuprofen can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01217",
                        "description": "The metabolism of Anastrozole can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The metabolism of Pitavastatin can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The metabolism of Levomilnacipran can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Estradiol acetate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Estradiol benzoate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Estradiol cypionate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Estradiol dienanthate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Estradiol valerate can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB08828",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Vismodegib"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Letermovir"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "The metabolism of Ozanimod can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00400",
                        "description": "The metabolism of Lapatinib can be increased when combined with Griseofulvin"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The metabolism of Lapatinib can be increased when combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The metabolism of Lapatinib can be increased when combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Lapatinib can be increased when combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Lapatinib can be increased when combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The metabolism of Hydrocortisone butyrate can be increased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB14542",
                        "description": "The metabolism of Hydrocortisone phosphate can be increased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The metabolism of Fluorouracil can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Amiodarone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00736",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Esomeprazole"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Ethanol"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Memantine"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB05351",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Dexlansoprazole"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Dovitinib"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB11638",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Artenimol"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Pantoprazole"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Olanzapine"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Felbamate"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Telmisartan"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Clevidipine"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06414",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Etravirine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Gestodene"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB12319",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Benzbromarone"
                    },
                    {
                        "drugbank-id": "DB13941",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Piperaquine"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB06442",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Avasimibe"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB01006",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Letrozole"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The metabolism of Lapatinib can be increased when combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB00615",
                        "description": "The metabolism of Lapatinib can be increased when combined with Rifabutin"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Carisoprodol"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Methohexital"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Albendazole"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Thiopental"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Ramelteon"
                    },
                    {
                        "drugbank-id": "DB01058",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Praziquantel"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Proguanil"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The metabolism of Hexobarbital can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The metabolism of Barbital can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The metabolism of Lacosamide can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The metabolism of Etizolam can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "The metabolism of Lynestrenol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13762",
                        "description": "The metabolism of Dexrabeprazole can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Testosterone"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Glyburide"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The metabolism of Nebivolol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Vilazodone can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Zolpidem"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The metabolism of Esketamine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The metabolism of Tegafur can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Lapatinib can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Lapatinib can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Lapatinib can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Lapatinib can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Lapatinib can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Lapatinib can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Lapatinib can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Lapatinib can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Lapatinib can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Lapatinib can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Lapatinib can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Lapatinib can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Lapatinib can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Lapatinib can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Lapatinib can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00066",
                        "description": "The therapeutic efficacy of Follitropin can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The therapeutic efficacy of Liothyronine can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "The therapeutic efficacy of Carbimazole can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB03374",
                        "description": "The therapeutic efficacy of 3 5 Diiodotyrosine can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "The therapeutic efficacy of Tiratricol can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB05084",
                        "description": "The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB05829",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06285",
                        "description": "The therapeutic efficacy of Teriparatide can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB07637",
                        "description": "The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "The therapeutic efficacy of Thyroid porcine can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB09421",
                        "description": "The therapeutic efficacy of Protirelin can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12629",
                        "description": "The therapeutic efficacy of 3 5 diiodothyropropionic acid can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13644",
                        "description": "The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13742",
                        "description": "The therapeutic efficacy of Elcatonin can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13804",
                        "description": "The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB15263",
                        "description": "The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The therapeutic efficacy of Lapatinib can be decreased when used in combination with Liotrix"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The bioavailability of Digoxin can be increased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The bioavailability of Metildigoxin can be increased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The bioavailability of Acetyldigoxin can be increased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "Lapatinib may increase the hepatotoxic activities of Pexidartinib"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lapatinib may increase the QTc prolonging activities of Lefamulin"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The serum concentration of Voxelotor can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Lapatinib can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The serum concentration of Levamlodipine can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Rimegepant can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The serum concentration of Lapatinib can be increased when it is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Lapatinib can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Lapatinib can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Pralsetinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Lapatinib"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}